News – Page 888 – Endpoints News

Hey, wait up Amgen and Mirati, Boehringer Ingelheim is joining the KRAS crowd as early success inspires rivals

6 years ago

TG Therapeutics touts safer PI3Kδ inhibitor as execs tout PhII data, hunt quick OK for a tough niche

6 years ago

Dupixent cleared for chronic rhinosinusitis in EU; FDA grants RMAT status to CARsgen's CAR-T

6 years ago

GSK team clinches positive trial for the first potential new TB vaccine in a century — with millions of lives at ...

6 years ago

FDA drafts guidance on Type V DMFs for combination products

6 years ago

Novartis' $111M bet on IL-17C drug turns sour — but MorphoSys, Galapagos will explore options

6 years ago

Atlas, Novo-backed biotech reels in ex-Nimbus CEO Don Nicholson as exec chairman, hooks $50M to conquer anemia

6 years ago

Roche — surprise — delays $4.3B Spark buyout again as regulators hover

6 years ago

Boston jury finds biotech CEO guilty of fleecing investors, obstruction of justice

6 years ago

Mirati team demonstrates that their KRAS G12C drug is active in NSCLC — but how do they stack up next to Amgen?

6 years ago

AstraZeneca’s triplet with Imfinzi, treme and chemo works on a key endpoint for frontline lung cancer

6 years ago

Here’s a new way to raise money for your biotech. This trailblazer came out $61M ahead with a place on the NYSE

6 years ago

FDA backs Mike Grey's bet on a comeback drug play with breakthrough status for maralixibat

6 years ago

Allergan ties up Namenda loose ends with $750M settlement

6 years ago

FDA accepts Heron's painkiller re-submission; splits Blueprint Medicines' NDA for avapritinib

6 years ago

A deal-hungry Vertex ushers in three more gene editing programs as it closes out harbinger CRISPR deal

6 years ago

David Hung is back, launching a new oncology startup with $275M and big ambitions to make news in cancer drug ...

6 years ago

Google’s venture arm recruits a Harvard/Tesaro vet to help plant the seeds for a second oncology R&D revolution

6 years ago

Mixed early data on Agios' AG-270 suggest combo therapy could be way forward

6 years ago

A GSK-led consortium looks to break ground with a new class of antibiotic, pushing into a pivotal

6 years ago

Ascentage soars during its first day on the Hong Kong exchange, following $53M debut

6 years ago

The human element: A biotech upstart hopes to carve a path around faulty animal models

6 years ago

Diving deep into AMD, Yale researchers pinpoint cell types drug developers should pay special attention to

6 years ago

China's Fountain Medical scores $62M as demand for CRO services surges

6 years ago

First page Previous page 885 886 887888889 890 891 Next page Last page